The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function
Recruiting
N/A
Interventional Study
Leiomyoma (Uterine Fibroids)
Adenomyoma of Uterus
Uterine Bleeding
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Erkan Gol · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day compl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women aged ≥18 years
* Planned total abdominal hysterectomy for benign indications
* Sexually active within the last 4 weeks
* Able to complete the Female Sexual Function Index (FSFI) questionnaire
* Provided written informed consent
Exclusion Criteria:
* Gynecologic maligna…
Contacts